Joint Working initiatives are not a new
phenomenon, but with major changes expected to impact the
NHS in the coming months and healthcare systems across the world in
the coming years, we can expect increased collaboration between the
pharmaceutical industry and healthcare providers, in order to
target specific issues and improve patient care.
Why is this likely to happen?
Although there are many contributing factors, the burden of an
ageing population in Western countries, as well as changing
lifestyles, is placing a greater strain on increasingly
cash-strapped and efficiency-seeking healthcare systems.
What is the impact for Pharma?
Pharmaceutical companies are already adapting their
business models and structures to provide more customer- and
patient-centric offerings, and employing more collaborative
approaches to working with customers. Joint Working initiatives
offer many tangible opportunities to embrace partnership with
healthcare providers.
Where does learning fit into this?
A fundamental aspect of many Joint Working initiatives is the
requirement for healthcare professionals to rapidly adopt new
practices, skills and knowledge in a relatively short timeframe.
Crucial to these changes is the provision of learning support and
educational programmes that are practically relevant, optimized for
target audience engagement, and ultimately effective at bringing
about the desired learning outcome.
